When to Use Discrete Event Simulation (DES) for the Economic Evaluation of Health Technologies? A Review and Critique of the Costs and Benefits of DES
PharmacoEconomics, 2014-06, Vol.32 (6), p.547-558 [Peer Reviewed Journal]Springer International Publishing Switzerland 2014 ;2015 INIST-CNRS ;COPYRIGHT 2014 Springer ;Copyright Wolters Kluwer Health Adis International Jun 2014 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-014-0147-9 ;PMID: 24627341
Full text available